Compugen (CGEN) Revenue (QoQ) (2009 - 2026)
Compugen (CGEN) Revenue (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Compugen | 221.26 Mn | 129.51 Mn | 352,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -96.77% |
| Dec 31, 2025 | 3,460.66% |
| Sep 30, 2025 | 50.44% |
| Jun 30, 2025 | -44.96% |
| Mar 31, 2025 | 55.27% |
| Dec 31, 2024 | -91.41% |
| Sep 30, 2024 | 155.63% |
| Jun 30, 2024 | 161.90% |
| Mar 31, 2024 | -92.35% |
| Dec 31, 2016 | -24.29% |
| Sep 30, 2016 | -85.89% |
| Jun 30, 2016 | 433.33% |
| Mar 31, 2016 | -98.88% |
| Dec 31, 2015 | 3,530.13% |
| Sep 30, 2015 | 2.69% |
| Jun 30, 2015 | -56.53% |
| Mar 31, 2015 | -92.17% |
| Dec 31, 2014 | 281.37% |
| Sep 30, 2014 | -12.53% |
| Jun 30, 2014 | -7.92% |